Empty Capsules Market

7500+ companies worldwide approach us every year for their revenue growth initiatives
Global top 2000 strategist rely on us for their growth strategies.
80% of fortune 2000 companies rely on our research to identify new revenue sources.
30000 High Growth Opportunities
95% renewal rate
KNOW MORE
  1. HOME
  2. Top Market Reports
  3. Empty Capsules Market

Empty Capsules Market Size, Share & Trends By Type (Gelatin (Porcine, Bovine, Bonemeal), Non-Gelatin (HPMC, Starch)), Functionality (Immediate-Release, Sustained-Release, Delayed-Release), Therapeutic Application (Antibiotic, Dietary, Antacid, CVD) & Region - Global Forecast to 2029

FREE BROCHURE FREE SAMPLE REPORT
Report Code: PH 2935 Jun, 2024, by marketsandmarkets.com

Empty Capsules Market Size, Share & Trends

Empty capsules market is projected to reach USD 4.2 billion by 2029 from an estimated USD 3.1 billion in 2024 at the rate of 6.3% CAGR during the forecast period. The growth of the market is driven by technological advancements such as entric coating to protect drugs or nutrients from stomach acids, controlled-release capsules for targeted and sustained drug delivery. Furthemore, demographic shift towards non-animal-derived ingredients and advantages of non-gelatin capsules over gelatin capsules such as superior stability is likely to give momentum to the growth of the non-gelatin empty capsules market. Rising investment in development of veg capsules and launch of novel veg capsules in the market by key market is futher likley to boost the market growth. For instance, in February 2023, Vivion, Inc., introduced new product range launch of empty gelatin, HPMC and pullulan capsules.

Empty Capsules Market Trends

Empty Capsules Market

To know about the assumptions considered for the study, Request for Free Sample Report

Empty Capsules Market

Global Empty Capsules Market Dynamics

DRIVER: Increasing demand for nutraceuticals

Mostly administered in capsules, nutraceuticals abound in fibre, antioxidants, heart-healthy components, vitamins, minerals, omega-3 fatty acids, calcium, and whole grains. Globally, growing health-conscious behaviours have driven demand for nutraceuticals as individuals give physical and mental well-being top priority via well-balanced diets and focused supplements top priority. Weighted towards a healthy gut, children, vision and sleep are the major focus trends. A study conducted in 318 Indian districts comprising more than 47,000 respondents showed that 71% of those surveyed consume nutraceuticals on a regular basis which reflects a major transition to health-conscious behavior. In addition, there is growing interest in CBD-based products as well as mental health among others, the sector is projected to hit USD 261.7 billion worth of nutraceutical components market by 2027 while plant-based substitutes.

RESTRAINT:  Dietary restrictions and issues with gelatin

Originally utilised extensively in the pharmaceutical and nutraceutical sectors, gelatin is the original and most often used component for making capsules. It is not fit for those with religious or dietary restrictions against animal products since it comes from the collagen of animal by-products including bones, skins, and hooves. The demand for vegetarian capsules—which are also more suitable for religious reasons—classified as Kosher and Halal—has grown along with the rise in vegetarian and vegan diets. Unlike gelatin capsules, which are only suitable for powdered drugs or supplements, vegetarian capsules satisfy a wider client base and are compatible with other substances. These elements are controlling the expansion of the capsule market based on gelatin.

OPPORTUNITY: Expansion of capsule production in emerging economies

The normally robust pharmaceuticals sector is finding challenges from a shrinking medicine pipeline, government pressure to cut costs, and strict regulations on new products. Low-cost manufacturing, attractive tax rates, and relaxed regulations help this situation inspire empty capsule manufacturers to move their operations to high growth developing areas. Big companies are raising their capacity in these regions to meet the increased demand for empty capsules and boost pharmaceutical output. For example, a major South Korean company opened a plant in Vietnam in May 2022, therefore significantly increasing its annual capsule production. Likewise, in February 2021 a European corporation started to be more visible in South Asia. Many pharmaceutical businesses are adopting contract manufacturing—focusing on core activities while outsourcing production—to offset profit margin constraints from cost-cutting and legislative changes, hence generating predicted demand for empty capsules.

CHALLENGES: Increasing prices and low availability of raw materials

Because of the differences between the demand and supply growth rates of gelatin, changing gelatin prices are having a major effect on the empty capsules market. While the demand for collagen, which mostly consumes gelatin, is forecast to spike at a strong CAGR of 8.25%, the gelatin market is expected to increase modestly in the United States at a CAGR of 3.3%. This higher demand for collagen strains gelatin supply for various applications, including empty capsule manufacture. Further aggravating the scenario are supply limitations including limited availability of raw materials including hides, bones, and pigskin and decreasing cattle slaughter levels. These elements build a major obstacle to the expansion of the empty capsule industry.

Global Empty Capsules Market Ecosystem Analysis

Raw material suppliers offer gelatin and HPMC in the empty capsules market; product manufacturers create the capsules following strict quality and regulatory standards. These capsules find use in end consumers in the pharmaceutical, nutraceutical, cosmetic, and research domains. Regulatory authorities guarantee public health by means of safety and quality compliance. These players taken together help several sectors by enabling the effective manufacture, transportation, and use of empty capsules, therefore promoting world healthcare and research.

Empty Capsules Market

Gelatin segment held a dominant share in the type of segment in the empty capsules market

Based on the type, the empty capsules market has been segmented into gelatin and non-gelatin capsules. The gelatin capsules segment is further categorized as porcine gelatin, bovine-derived gelatin, bone meal, and other gelatin sources. The non-gelatin capsules segment is further categorized as hydroxypropyl methylcellulose (HPMC) capsules, and pullulan & starch capsules. In 2023, gelatin capsules segment accounted for the largest share of the empty capsules market.

Gelatin capsules segment dominated the market due to the compatibility with a wide range of active ingredients, and cost-effectiveness. Non-gelatin capsules are likely to grow at significant CAGR during the forecast period owing to launch of new products in the market and rise in adoption of veg capsules among patient populations across the globe.

The dietary supplements segment is expected to register the fastest growth during the forecast period.

Based on the therapeutic application of empty capsules, the market has been segmented into antibiotic & antibacterial drugs, dietary supplements, antacid & antiflatulent preparations, antianemic preparations, anti-inflammatory drugs, cardiovascular therapy drugs, cough & cold drugs, other therapeutic applications. In 2023, antibiotic & antibacterial drugs segment accounted for the largest share. Over the projected period, the segment on dietary supplements is likely to have the greatest CAGR. The growing consumer attention on health and wellbeing, which results in more demand for dietary supplements, drives the empty capsule market in dietary supplements. Furthermore, new capsule formulations including vegetarian and vegan choices appeal to a larger audience and help to increase market growth.

North America accounted for the largest share in empty capsules market in 2023

Geologically, the empty capsules market is broken out into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. First in share was North America, then Europe. Empty capsules in North America are driven by the increased need for dietary supplements and medications, developments in capsule production techniques, and customer inclination for quick and easy dose forms. Moreover, a great focus on preventive health drives regional market growth.

Empty Capsules Market by Region

To know about the assumptions considered for the study, download the pdf brochure

Key Market Players

Key players in the global empty capsules market include Capsugel (Lonza) (Switzerland), ACG (India), QUALICAPS (Roquette Frères) (France), SUHEUNG (South Korea), Shanxi Guangsheng Capsule Limited (China), CapsCanada (Lyfe Group) (US), HealthCaps India (India), Nectar Lifesciences Ltd. (India), Sunil Healthcare Limited (India), Farmacapsulas (Colombia), NATURAL CAPSULES LIMITED (India), Erawat Pharma Limited (India), Qingdao Yiqing Biotechnology Co., Ltd. (Baotou Dongbao Bio-Tech Co., Ltd.) (China), Fortcaps ( Kumar Organic Products Limited) (India), Comed Chemicals Limited  (India), Roxlor (US), Medisca Inc. (US), Zhejiang Yuexi Capsule Co. (China), ZHEJIANG HUILI CAPSULES CO., LTD (China), Shaoxing Zhongya Capsule Co., Ltd. (China), Shing Lih Fang Enterprise Co., Ltd. (Taiwan), Chemcaps Limited (India), SNAIL PHARMA INDUSTRY (China), SavoiurCaps (India), Shanxi JC Biological Technology CO.  (China), Shaoxing Kangke Capsule Co., Ltd.  (China), Lefancaps (Canada), BIO-CAPS INDIA LTD. (India), BioCaps Enterprise (US), Bright Pharma Caps (US), and SHREE PHARMA CAPS (India).

Scope of the In Vitro Toxicology Testing Industry:

Report Metric

Details

Market Revenue in 2024

$3.1 billion

Estimated Value by 2029

$4.2 billion

Revenue Rate

Poised to grow at a CAGR of 6.3%

Market Driver

Increasing demand for nutraceuticals

Market Opportunity

Expansion of capsule production in emerging economies

This report categorizes the global empty capsules market to forecast revenue and analyze trends in each of the following submarkets:

By Type
  • Gelatin Capsules (Value (USD Million) & Volume (Billion Units))
    • Porcine Gelatin
    • Bovine-derived Gelatin
    • Bone Meal Gelatin
    • Other Gelatin Sources
  • Non-gelatin Capsules (Value (USD Million) & Volume (Billion Units)
    • Hydroxypropyl Methylcellulose (HPMC)
    • Pullulan & Starch
By Functionality
  • Immediate-release Capsules
  • Sustained-release Capsules
  • Delayed-release Capsules
By Therapeutic Application
  • Antibiotic & antibacterial drugs
  • Dietary supplements
  • Antacid & antiflatulent preparations
  • Antianemic preparations
  • Anti-inflammatory drugs
  • Cardiovascular therapy drugs
  • Cough & cold drugs
  • Other therapeutic applications
By End User
  • Pharmaceutical Industry
  • Nutraceutical Industry
  • Cosmetic Industry
  • Research Laboratories
By Region
  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • RoE
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • RoAPAC
  • Latin America
    • Brazil
    • Mexico
    • RoLATAM
  • Middle East & Africa

Recent Developments

  • In October 2023 Roquette purchased pharmaceutical instruments to improve worldwide presence and Qualicaps, a producer of hard capsules. Thus, it not only provided oral dosage solutions all around but also enhanced ground-up versions of them. By combining two companies like Roquette and Qualicaps then the new company will be able to advance technically along with improving services in order to provide customers an extensive range from generic capsules or full binders including others such fillers used in this field for years past decades present day but not future times yet.
  • Capugel Enprotect presented the first coating-free capsule for intestinal (enteric) medicine delivery in November 2022. Aiming at small chemicals, peptides, proteins, and RNA-based treatments, this novel delivery technology seeks to It also looks at making live biotherapeutic objects feasible.
  • ACG made an agreement with the Government of Maharashtra (India) in December 2021 to construct the largest capsule manufacturing unit in Asia at Aurangabad. This facility will output 40 billion capsules per year, which will be utilized by local as well as global nutraceutical and pharmaceutical firms.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS
 
1 INTRODUCTION (Page No. - 43)
    1.1 STUDY OBJECTIVES 
    1.2 MARKET DEFINITION 
           1.2.1 INCLUSIONS & EXCLUSIONS
    1.3 MARKET SCOPE 
           1.3.1 MARKETS COVERED
           1.3.2 REGIONS COVERED
           1.3.3 YEARS CONSIDERED
    1.4 UNITS CONSIDERED 
           1.4.1 CURRENCY/VALUE UNIT
           1.4.2 VOLUME UNIT
    1.5 STAKEHOLDERS 
    1.6 SUMMARY OF CHANGES 
    1.7 RECESSION IMPACT 
 
2 RESEARCH METHODOLOGY (Page No. - 48)
    2.1 RESEARCH APPROACH 
          FIGURE 1 RESEARCH DESIGN
           2.1.1 SECONDARY DATA
           2.1.2 PRIMARY DATA
                    FIGURE 2 EMPTY CAPSULES MARKET: BREAKDOWN OF PRIMARIES
    2.2 MARKET ESTIMATION METHODOLOGY 
          FIGURE 3 EMPTY CAPSULES INDUSTRY SIZE ESTIMATION, BY VALUE (2023)
           2.2.1 BOTTOM-UP APPROACH
                    FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2023
                    FIGURE 5 MARKET SIZE ESTIMATION, BY VOLUME (2023)
           2.2.2 INSIGHTS FROM PRIMARY EXPERTS
                    FIGURE 6 INSIGHTS FROM PRIMARY EXPERTS
           2.2.3 TOP-DOWN APPROACH
                    FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
    2.3 MARKET GROWTH RATE PROJECTIONS 
          TABLE 1 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS
    2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 
          FIGURE 8 DATA TRIANGULATION METHODOLOGY
    2.5 RESEARCH ASSUMPTIONS 
    2.6 RESEARCH LIMITATIONS 
    2.7 RISK ANALYSIS 
          TABLE 2 RISK ASSESSMENT ANALYSIS
    2.8 RECESSION IMPACT ANALYSIS 
 
3 EXECUTIVE SUMMARY (Page No. - 61)
    FIGURE 9 EMPTY CAPSULES MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
    FIGURE 10 EMPTY CAPSULES INDUSTRY, BY FUNCTIONALITY, 2024 VS. 2029 (USD MILLION)
    FIGURE 11 MARKET, BY THERAPEUTIC APPLICATION, 2024 VS. 2029 (USD MILLION)
    FIGURE 12 MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
    FIGURE 13 GEOGRAPHIC SNAPSHOT OF MARKET
 
4 PREMIUM INSIGHTS (Page No. - 65)
    4.1 EMPTY CAPSULES MARKET OVERVIEW 
          FIGURE 14 INCREASING DEMAND FOR NUTRACEUTICALS TO DRIVE MARKET
    4.2 NORTH AMERICA: EMPTY CAPSULES INDUSTRY, BY TYPE AND COUNTRY (2023) 
          FIGURE 15 GELATIN CAPSULES SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2023
    4.3 MARKET, BY THERAPEUTIC APPLICATION (2023) 
          FIGURE 16 ANTIBIOTIC & ANTIBACTERIAL DRUGS SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2023
    4.4 MARKET, BY END USER (2023) 
          FIGURE 17 PHARMACEUTICAL INDUSTRY SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2023
    4.5 MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 
          FIGURE 18 ASIA PACIFIC COUNTRIES TO REGISTER HIGHER GROWTH RATE DURING FORECAST PERIOD
 
5 MARKET OVERVIEW (Page No. - 68)
    5.1 INTRODUCTION 
    5.2 MARKET DYNAMICS 
          FIGURE 19 EMPTY CAPSULES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
          TABLE 3 EMPTY CAPSULES INDUSTRY: IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
           5.2.1 DRIVERS
                    5.2.1.1 Increasing demand for nutraceuticals
                    5.2.1.2 Growing focus on pharmaceutical development and subsequent increase in clinical trials
                                FIGURE 20 TOTAL PRESCRIPTION DRUG SALES, 2014−2028 (USD BILLION)
                                FIGURE 21 NUMBER OF CLINICAL TRIALS REGISTERED, 2001−2023
                    5.2.1.3 Advancements in capsule delivery technologies
                    5.2.1.4 Benefits of capsules over other dosage forms
                    5.2.1.5 Growing preference for self-medication and OTC drugs
           5.2.2 RESTRAINTS
                    5.2.2.1 Dietary restrictions associated with gelatin consumption
                    5.2.2.2 Issues related to safety and efficacy
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Expansion of capsule production in emerging economies
                    5.2.3.2 Development of halal gelatin and vegetarian capsules
           5.2.4 CHALLENGES
                    5.2.4.1 Variable prices and low availability of raw materials
                    5.2.4.2 Challenges associated with storage of empty capsules
    5.3 INDUSTRY TRENDS 
           5.3.1 RISING DEMAND FOR EMPTY CAPSULES IN NUTRACEUTICALS & COSMETICS
           5.3.2 GROWING PREFERENCE FOR VEGETARIAN/NON-GELATIN CAPSULES
    5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 
          FIGURE 22 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES IN MARKET
    5.5 SUPPLY CHAIN ANALYSIS 
          FIGURE 23 MARKET: SUPPLY CHAIN ANALYSIS
    5.6 PRICING ANALYSIS 
          TABLE 4 AVERAGE SELLING PRICE TREND OF EMPTY CAPSULES, BY TYPE (2021−2023)
          TABLE 5 AVERAGE PRICE OF EMPTY CAPSULES, BY REGION (2023)
    5.7 TECHNOLOGY ANALYSIS 
           5.7.1 KEY TECHNOLOGIES
                    5.7.1.1 Advanced quality control systems
                    5.7.1.2 Automated encapsulation machines
           5.7.2 COMPLEMENTARY TECHNOLOGIES
                    5.7.2.1 3D printing
                    5.7.2.2 Enteric capsule technologies
           5.7.3 ADJACENT TECHNOLOGIES
                    5.7.3.1 Nanotechnology
                    5.7.3.2 AI in capsule manufacturing
    5.8 VALUE CHAIN ANALYSIS 
          FIGURE 24 MARKET: VALUE CHAIN ANALYSIS
    5.9 ECOSYSTEM ANALYSIS 
          FIGURE 25 MARKET: ECOSYSTEM ANALYSIS
           5.9.1 MARKET: ROLE OF RAW MATERIAL VENDORS
                    TABLE 6 MARKET: ROLE OF RAW MATERIAL VENDORS
           5.9.2 MARKET: ROLE OF PRODUCT PROVIDERS
                    TABLE 7 MARKET: ROLE OF PRODUCT PROVIDERS
           5.9.3 MARKET: ROLE OF END USERS
                    TABLE 8 MARKET: ROLE OF END USERS
           5.9.4 MARKET: ROLE OF REGULATORY AUTHORITIES
                    TABLE 9 MARKET: ROLE OF REGULATORY AUTHORITIES
    5.10 PORTER’S FIVE FORCES ANALYSIS 
           FIGURE 26 MARKET: PORTER’S FIVE FORCES ANALYSIS
           TABLE 10 MARKET: PORTER’S FIVE FORCES ANALYSIS
           5.10.1 THREAT OF NEW ENTRANTS
           5.10.2 THREAT OF SUBSTITUTES
           5.10.3 BARGAINING POWER OF SUPPLIERS
           5.10.4 BARGAINING POWER OF BUYERS
           5.10.5 INTENSITY OF COMPETITIVE RIVALRY
    5.11 PATENT ANALYSIS 
           5.11.1 PATENT METHODOLOGY
           5.11.2 PATENTS FILED, BY DOCUMENT TYPE, 2014−2024
                     TABLE 11 PATENTS FILED, 2014−2024
           5.11.3 INNOVATION & PATENT APPLICATIONS
                     FIGURE 27 TOTAL NUMBER OF PATENTS GRANTED, 2014−2024
           5.11.4 TOP APPLICANTS
                     FIGURE 28 TOP TEN PLAYERS WITH HIGHEST NUMBER OF PATENT APPLICATIONS, 2014−2024
                     TABLE 12 TOP 20 PATENT OWNERS IN EMPTY CAPSULES, 2014−2024
                     TABLE 13 INDICATIVE LIST OF PATENTS IN EMPTY CAPSULES INDUSTRY, 2023−2024
    5.12 KEY CONFERENCES & EVENTS, 2024–2025 
           TABLE 14 MARKET: DETAILED LIST OF CONFERENCES & EVENTS, 2024−2025
    5.13 TRADE ANALYSIS 
           TABLE 15 IMPORT VALUE FOR HS CODE 960200 (TOP 30 COUNTRIES), 2019−2023 (USD THOUSAND)
           TABLE 16 EXPORT VALUE FOR HS CODE 960200 (TOP 30 COUNTRIES), 2019−2023 (USD THOUSAND)
           TABLE 17 IMPORT VOLUME FOR HS CODE 960200 (TOP 30 COUNTRIES), 2019−2023 (TONS)
           TABLE 18 EXPORT VOLUME FOR HS CODE 960200 (TOP 30 COUNTRIES), 2019−2023 (TONS)
    5.14 REGULATORY LANDSCAPE 
           5.14.1 REGULATORY SCENARIO
           5.14.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                     TABLE 19 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                     TABLE 20 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                     TABLE 21 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                     TABLE 22 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    5.15 KEY STAKEHOLDERS AND BUYING CRITERIA 
           5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS
                     FIGURE 29 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR EMPTY CAPSULES
           5.15.2 BUYING CRITERIA FOR EMPTY CAPSULES
                     FIGURE 30 KEY BUYING CRITERIA FOR EMPTY CAPSULES
                     TABLE 23 BUYING CRITERIA FOR EMPTY CAPSULE PRODUCTS, BY END USER
    5.16 INVESTMENT & FUNDING SCENARIO 
    5.17 INSIGHTS ON PHARMACEUTICAL GELATIN MARKET 
 
6 EMPTY CAPSULES MARKET, BY TYPE (Page No. - 110)
    6.1 INTRODUCTION 
          TABLE 24 EMPTY CAPSULES INDUSTRY, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 25 MARKET, BY TYPE, 2022–2029 (BILLION UNITS)
    6.2 GELATIN CAPSULES 
          TABLE 26 GELATIN CAPSULES MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 27 GELATIN CAPSULES MARKET, BY REGION, 2022–2029 (USD MILLION)
          TABLE 28 GELATIN CAPSULES MARKET, BY REGION, 2022–2029 (BILLION UNITS)
          TABLE 29 NORTH AMERICA: GELATIN CAPSULES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 30 EUROPE: GELATIN CAPSULES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 31 ASIA PACIFIC: GELATIN CAPSULES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 32 LATIN AMERICA: GELATIN CAPSULES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
           6.2.1 PORCINE GELATIN
                    6.2.1.1 Porcine gelatin segment to dominate market
                                TABLE 33 PORCINE GELATIN CAPSULES MARKET, BY REGION, 2022–2029 (USD MILLION)
                                TABLE 34 NORTH AMERICA: PORCINE GELATIN CAPSULES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 35 EUROPE: PORCINE GELATIN CAPSULES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 36 ASIA PACIFIC: PORCINE GELATIN CAPSULES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 37 LATIN AMERICA: PORCINE GELATIN CAPSULES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
           6.2.2 BOVINE-DERIVED GELATIN
                    6.2.2.1 Growing demand for stabilizing agents in pharmaceutical formulations to drive market
                                TABLE 38 BOVINE-DERIVED GELATIN CAPSULES MARKET, BY REGION, 2022–2029 (USD MILLION)
                                TABLE 39 NORTH AMERICA: BOVINE-DERIVED GELATIN CAPSULES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 40 EUROPE: BOVINE-DERIVED GELATIN CAPSULES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 41 ASIA PACIFIC: BOVINE-DERIVED GELATIN CAPSULES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 42 LATIN AMERICA: BOVINE-DERIVED GELATIN CAPSULES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
           6.2.3 BONEMEAL GELATIN
                    6.2.3.1 Ability to be used as substitutes for porcine gelatin to boost demand
                                TABLE 43 BONEMEAL GELATIN CAPSULES MARKET, BY REGION, 2022–2029 (USD MILLION)
                                TABLE 44 NORTH AMERICA: BONEMEAL GELATIN CAPSULES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 45 EUROPE: BONEMEAL GELATIN CAPSULES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 46 ASIA PACIFIC: BONEMEAL GELATIN CAPSULES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 47 LATIN AMERICA: BONEMEAL GELATIN CAPSULES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
           6.2.4 OTHER GELATIN SOURCES
                    TABLE 48 OTHER GELATIN SOURCES MARKET, BY REGION, 2022–2029 (USD MILLION)
                    TABLE 49 NORTH AMERICA: OTHER GELATIN SOURCES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 50 EUROPE: OTHER GELATIN SOURCES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 51 ASIA PACIFIC: OTHER GELATIN SOURCES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 52 LATIN AMERICA: OTHER GELATIN SOURCES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
    6.3 NON-GELATIN CAPSULES 
          TABLE 53 NON-GELATIN CAPSULES MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 54 NON-GELATIN CAPSULES MARKET, BY REGION, 2022–2029 (USD MILLION)
          TABLE 55 NON-GELATIN CAPSULES MARKET, BY REGION, 2022–2029 (BILLION UNITS)
          TABLE 56 NORTH AMERICA: NON-GELATIN CAPSULES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 57 EUROPE: NON-GELATIN CAPSULES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 58 ASIA PACIFIC: NON-GELATIN CAPSULES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 59 LATIN AMERICA: NON-GELATIN CAPSULES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
           6.3.1 HYDROXYPROPYL METHYLCELLULOSE (HPMC) CAPSULES
                    6.3.1.1 Growing applications in pharmaceutical, nutraceutical, and OTC formulations to drive market
                                TABLE 60 HYDROXYPROPYL METHYLCELLULOSE CAPSULES MARKET, BY REGION, 2022–2029 (USD MILLION)
                                TABLE 61 NORTH AMERICA: HYDROXYPROPYL METHYLCELLULOSE CAPSULES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 62 EUROPE: HYDROXYPROPYL METHYLCELLULOSE CAPSULES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 63 ASIA PACIFIC: HYDROXYPROPYL METHYLCELLULOSE CAPSULES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 64 LATIN AMERICA: HYDROXYPROPYL METHYLCELLULOSE CAPSULES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
           6.3.2 PULLULAN & STARCH CAPSULES
                    6.3.2.1 High manufacturing cost to restrain market
                                TABLE 65 PULLULAN & STARCH CAPSULES MARKET, BY REGION, 2022–2029 (USD MILLION)
                                TABLE 66 NORTH AMERICA: PULLULAN & STARCH CAPSULES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 67 EUROPE: PULLULAN & STARCH CAPSULES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 68 ASIA PACIFIC: PULLULAN & STARCH CAPSULES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 69 LATIN AMERICA: PULLULAN & STARCH CAPSULES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
7 EMPTY CAPSULES MARKET, BY FUNCTIONALITY (Page No. - 133)
    7.1 INTRODUCTION 
          TABLE 70 EMPTY CAPSULES INDUSTRY, BY FUNCTIONALITY, 2022–2029 (USD MILLION)
    7.2 IMMEDIATE-RELEASE CAPSULES 
           7.2.1 RAPID ABSORPTION AND BROAD APPLICATIONS TO PROPEL MARKET
                    TABLE 71 IMMEDIATE-RELEASE CAPSULES MARKET, BY REGION, 2022–2029 (USD MILLION)
                    TABLE 72 NORTH AMERICA: IMMEDIATE-RELEASE CAPSULES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 73 EUROPE: IMMEDIATE-RELEASE CAPSULES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 74 ASIA PACIFIC: IMMEDIATE-RELEASE CAPSULES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 75 LATIN AMERICA: IMMEDIATE-RELEASE CAPSULES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
    7.3 SUSTAINED-RELEASE CAPSULES 
           7.3.1 CONTROLLED DRUG RELEASE FOR CHRONIC DISEASE MANAGEMENT TO DRIVE MARKET
                    TABLE 76 SUSTAINED-RELEASE CAPSULES MARKET, BY REGION, 2022–2029 (USD MILLION)
                    TABLE 77 NORTH AMERICA: SUSTAINED-RELEASE CAPSULES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 78 EUROPE: SUSTAINED-RELEASE CAPSULES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 79 ASIA PACIFIC: SUSTAINED-RELEASE CAPSULES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 80 LATIN AMERICA: SUSTAINED-RELEASE CAPSULES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
    7.4 DELAYED-RELEASE CAPSULES 
           7.4.1 GROWING PREFERENCE FOR TARGETED DRUG DELIVERY TO FUEL MARKET
                    TABLE 81 DELAYED-RELEASE CAPSULES MARKET, BY REGION, 2022–2029 (USD MILLION)
                    TABLE 82 NORTH AMERICA: DELAYED-RELEASE CAPSULES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 83 EUROPE: DELAYED-RELEASE CAPSULES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 84 ASIA PACIFIC: DELAYED-RELEASE CAPSULES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 85 LATIN AMERICA: DELAYED-RELEASE CAPSULES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
8 EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION (Page No. - 143)
    8.1 INTRODUCTION 
          TABLE 86 EMPTY CAPSULES INDUSTRY, BY THERAPEUTIC APPLICATION, 2022–2029 (USD MILLION)
    8.2 ANTIBIOTIC & ANTIBACTERIAL DRUGS 
           8.2.1 RISING INCIDENCE OF INFECTIOUS DISEASES TO DRIVE MARKET
                    TABLE 87 MARKET FOR ANTIBIOTICS & ANTIBACTERIAL DRUGS, BY REGION, 2022–2029 (USD MILLION)
                    TABLE 88 NORTH AMERICA: MARKET FOR ANTIBIOTICS & ANTIBACTERIAL DRUGS, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 89 EUROPE: MARKET FOR ANTIBIOTICS & ANTIBACTERIAL DRUGS, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 90 ASIA PACIFIC: MARKET FOR ANTIBIOTICS & ANTIBACTERIAL DRUGS, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 91 LATIN AMERICA: MARKET FOR ANTIBIOTICS & ANTIBACTERIAL DRUGS, BY COUNTRY, 2022–2029 (USD MILLION)
    8.3 DIETARY SUPPLEMENTS 
           8.3.1 HIGH UPTAKE OF MULTIVITAMINS TO BOOST DEMAND
                    TABLE 92 MARKET FOR DIETARY SUPPLEMENTS, BY REGION, 2022–2029 (USD MILLION)
                    TABLE 93 NORTH AMERICA: MARKET FOR DIETARY SUPPLEMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 94 EUROPE: MARKET FOR DIETARY SUPPLEMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 95 ASIA PACIFIC: MARKET FOR DIETARY SUPPLEMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 96 LATIN AMERICA: MARKET FOR DIETARY SUPPLEMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
    8.4 ANTACID & ANTIFLATULENT PREPARATIONS 
           8.4.1 APPLICATIONS IN GASTROINTESTINAL FORMULATIONS TO DRIVE MARKET
                    TABLE 97 MARKET FOR ANTACID & ANTIFLATULENT PREPARATIONS, BY REGION, 2022–2029 (USD MILLION)
                    TABLE 98 NORTH AMERICA: MARKET FOR ANTACID & ANTIFLATULENT PREPARATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 99 EUROPE: MARKET FOR ANTACID & ANTIFLATULENT PREPARATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 100 ASIA PACIFIC: MARKET FOR ANTACID & ANTIFLATULENT PREPARATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 101 LATIN AMERICA: MARKET FOR ANTACID AND ANTIFLATULENT PREPARATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
    8.5 ANTIANEMIC PREPARATIONS 
           8.5.1 RISING PREVALENCE OF ANEMIA TO SUPPORT MARKET GROWTH
                    TABLE 102 MARKET FOR ANTIANEMIC PREPARATIONS, BY REGION, 2022–2029 (USD MILLION)
                    TABLE 103 NORTH AMERICA: MARKET FOR ANTIANEMIC PREPARATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 104 EUROPE: MARKET FOR ANTIANEMIC PREPARATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 105 ASIA PACIFIC: MARKET FOR ANTIANEMIC PREPARATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 106 LATIN AMERICA: MARKET FOR ANTIANEMIC PREPARATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
    8.6 ANTI-INFLAMMATORY DRUGS 
           8.6.1 GROWING PREFERENCE FOR NSAIDS AND DMARDS TO PROPEL MARKET
                    TABLE 107 MARKET FOR ANTI-INFLAMMATORY DRUGS, BY REGION, 2022–2029 (USD MILLION)
                    TABLE 108 NORTH AMERICA: MARKET FOR ANTI-INFLAMMATORY DRUGS, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 109 EUROPE: MARKET FOR ANTI-INFLAMMATORY DRUGS, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 110 ASIA PACIFIC: MARKET FOR ANTI-INFLAMMATORY DRUGS, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 111 LATIN AMERICA: MARKET FOR ANTI-INFLAMMATORY DRUGS, BY COUNTRY, 2022–2029 (USD MILLION)
    8.7 CARDIOVASCULAR THERAPY DRUGS 
           8.7.1 INCREASING PREVALENCE OF CVD TO SUPPORT MARKET GROWTH
                    TABLE 112 EMPTY CAPSULES INDUSTRY FOR CARDIOVASCULAR THERAPY DRUGS, BY REGION, 2022–2029 (USD MILLION)
                    TABLE 113 NORTH AMERICA: MARKET FOR CARDIOVASCULAR THERAPY DRUGS, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 114 EUROPE: MARKET FOR CARDIOVASCULAR THERAPY DRUGS, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 115 ASIA PACIFIC: MARKET FOR CARDIOVASCULAR THERAPY DRUGS, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 116 LATIN AMERICA: MARKET FOR CARDIOVASCULAR THERAPY DRUGS, BY COUNTRY, 2022–2029 (USD MILLION)
    8.8 COUGH & COLD DRUGS 
           8.8.1 GROWING PREFERENCE FOR OTC FORMULATIONS TO BOOST DEMAND
                    TABLE 117 MARKET FOR COUGH & COLD DRUGS, BY REGION, 2022–2029 (USD MILLION)
                    TABLE 118 NORTH AMERICA: MARKET FOR COUGH & COLD DRUGS, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 119 EUROPE: MARKET FOR COUGH & COLD DRUGS, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 120 ASIA PACIFIC: MARKET FOR COUGH & COLD DRUGS, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 121 LATIN AMERICA: MARKET FOR COUGH & COLD DRUGS, BY COUNTRY, 2022–2029 (USD MILLION)
    8.9 OTHER THERAPEUTIC APPLICATIONS 
          TABLE 122 MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
          TABLE 123 NORTH AMERICA: MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 124 EUROPE: MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 125 ASIA PACIFIC: MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 126 LATIN AMERICA: MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
 
9 EMPTY CAPSULES MARKET, BY END USER (Page No. - 164)
    9.1 INTRODUCTION 
          TABLE 127 EMPTY CAPSULES INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
    9.2 PHARMACEUTICAL INDUSTRY 
           9.2.1 INCREASING FOCUS ON DRUG DISCOVERY & DEVELOPMENT ACTIVITIES TO PROPEL MARKET
                    TABLE 128 MARKET FOR PHARMACEUTICAL INDUSTRY, BY REGION, 2022–2029 (USD MILLION)
                    TABLE 129 NORTH AMERICA: MARKET FOR PHARMACEUTICAL INDUSTRY, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 130 EUROPE: MARKET FOR PHARMACEUTICAL INDUSTRY, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 131 ASIA PACIFIC: MARKET FOR PHARMACEUTICAL INDUSTRY, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 132 LATIN AMERICA: MARKET FOR PHARMACEUTICAL INDUSTRY, BY COUNTRY, 2022–2029 (USD MILLION)
    9.3 NUTRACEUTICAL INDUSTRY 
           9.3.1 GROWING DEMAND FOR DIETARY SUPPLEMENTS TO BOOST DEMAND
                    TABLE 133 MARKET FOR NUTRACEUTICAL INDUSTRY, BY REGION, 2022–2029 (USD MILLION)
                    TABLE 134 NORTH AMERICA: MARKET FOR NUTRACEUTICAL INDUSTRY, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 135 EUROPE: MARKET FOR NUTRACEUTICAL INDUSTRY, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 136 ASIA PACIFIC: MARKET FOR NUTRACEUTICAL INDUSTRY, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 137 LATIN AMERICA: MARKET FOR NUTRACEUTICAL INDUSTRY, BY COUNTRY, 2022–2029 (USD MILLION)
    9.4 COSMETICS INDUSTRY 
           9.4.1 RISING FOCUS ON HOLISTIC WELLNESS TO SUPPORT MARKET GROWTH
                    TABLE 138 MARKET FOR COSMETIC INDUSTRY, BY REGION, 2022–2029 (USD MILLION)
                    TABLE 139 NORTH AMERICA: MARKET FOR COSMETIC INDUSTRY, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 140 EUROPE: MARKET FOR COSMETIC INDUSTRY, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 141 ASIA PACIFIC: MARKET FOR COSMETIC INDUSTRY, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 142 LATIN AMERICA: MARKET FOR COSMETIC INDUSTRY, BY COUNTRY, 2022–2029 (USD MILLION)
    9.5 RESEARCH LABORATORIES 
           9.5.1 INCREASING CLINICAL TRIALS TO SUPPORT MARKET GROWTH
                    TABLE 143 MARKET FOR RESEARCH LABORATORIES, BY REGION, 2022–2029 (USD MILLION)
                    TABLE 144 NORTH AMERICA: MARKET FOR RESEARCH LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 145 EUROPE: MARKET FOR RESEARCH LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 146 ASIA PACIFIC: MARKET FOR RESEARCH LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 147 LATIN AMERICA: MARKET FOR RESEARCH LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
 
10 EMPTY CAPSULES MARKET, BY REGION (Page No. - 176)
     10.1 INTRODUCTION 
             TABLE 148 EMPTY CAPSULES INDUSTRY, BY REGION, 2022–2029 (USD MILLION)
             TABLE 149 EMPTY CAPSULES INDUSTRY, BY REGION, 2022–2029 (BILLION UNITS)
     10.2 NORTH AMERICA 
             10.2.1 NORTH AMERICA: RECESSION IMPACT
                        FIGURE 31 NORTH AMERICA: EMPTY CAPSULES MARKET SNAPSHOT
                        TABLE 150 NORTH AMERICA: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                        TABLE 151 NORTH AMERICA: MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 152 NORTH AMERICA: GELATIN CAPSULES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 153 NORTH AMERICA: NON-GELATIN CAPSULES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 154 NORTH AMERICA: MARKET, BY FUNCTIONALITY, 2022–2029 (USD MILLION)
                        TABLE 155 NORTH AMERICA: MARKET, BY THERAPEUTIC APPLICATION, 2022–2029 (USD MILLION)
                        TABLE 156 NORTH AMERICA: MARKET, BY END USER, 2022–2029 (USD MILLION)
             10.2.2 US
                        10.2.2.1 Rising demand for generic drugs to fuel market
                                      TABLE 157 US: EMPTY CAPSULES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 158 US: GELATIN CAPSULES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 159 US: NON-GELATIN CAPSULES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 160 US: MARKET, BY FUNCTIONALITY, 2022–2029 (USD MILLION)
                                      TABLE 161 US: MARKET, BY THERAPEUTIC APPLICATION, 2022–2029 (USD MILLION)
                                      TABLE 162 US: MARKET, BY END USER, 2022–2029 (USD MILLION)
             10.2.3 CANADA
                        10.2.3.1 Growing focus on nutraceutical exports to propel market
                                      TABLE 163 CANADA: EMPTY CAPSULES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 164 CANADA: GELATIN CAPSULES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 165 CANADA: NON-GELATIN CAPSULES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 166 CANADA: MARKET, BY FUNCTIONALITY, 2022–2029 (USD MILLION)
                                      TABLE 167 CANADA: MARKET, BY THERAPEUTIC APPLICATION, 2022–2029 (USD MILLION)
                                      TABLE 168 CANADA: EMPTY CAPSULES MARKET, BY END USER, 2022–2029 (USD MILLION)
     10.3 EUROPE 
             10.3.1 EUROPE: RECESSION IMPACT
                        TABLE 169 EUROPE: EMPTY CAPSULES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                        TABLE 170 EUROPE: MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 171 EUROPE: GELATIN CAPSULES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 172 EUROPE: NON-GELATIN CAPSULES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 173 EUROPE: MARKET, BY FUNCTIONALITY, 2022–2029 (USD MILLION)
                        TABLE 174 EUROPE: MARKET, BY THERAPEUTIC APPLICATION, 2022–2029 (USD MILLION)
                        TABLE 175 EUROPE: EMPTY CAPSULES MARKET, BY END USER, 2022–2029 (USD MILLION)
             10.3.2 GERMANY
                        10.3.2.1 High demand for capsule-based pharma & nutraceutical formulations to propel market
                                      TABLE 176 GERMANY: EMPTY CAPSULES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 177 GERMANY: GELATIN CAPSULES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 178 GERMANY: NON-GELATIN CAPSULES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 179 GERMANY: MARKET, BY FUNCTIONALITY, 2022–2029 (USD MILLION)
                                      TABLE 180 GERMANY: MARKET, BY THERAPEUTIC APPLICATION, 2022–2029 (USD MILLION)
                                      TABLE 181 GERMANY: MARKET, BY END USER, 2022–2029 (USD MILLION)
             10.3.3 UK
                        10.3.3.1 Low cost of generics to boost demand
                                      TABLE 182 UK: EMPTY CAPSULES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 183 UK: GELATIN CAPSULES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 184 UK: NON-GELATIN CAPSULES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 185 UK: MARKET, BY FUNCTIONALITY, 2022–2029 (USD MILLION)
                                      TABLE 186 UK: MARKET, BY THERAPEUTIC APPLICATION, 2022–2029 (USD MILLION)
                                      TABLE 187 UK: MARKET, BY END USER, 2022–2029 (USD MILLION)
             10.3.4 FRANCE
                        10.3.4.1 Ban on bovine-based food-grade gelatin to restrain market
                                      TABLE 188 FRANCE: EMPTY CAPSULES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 189 FRANCE: GELATIN CAPSULES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 190 FRANCE: NON-GELATIN CAPSULES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 191 FRANCE: MARKET, BY FUNCTIONALITY, 2022–2029 (USD MILLION)
                                      TABLE 192 FRANCE: MARKET, BY THERAPEUTIC APPLICATION, 2022–2029 (USD MILLION)
                                      TABLE 193 FRANCE: EMPTY CAPSULES MARKET, BY END USER, 2022–2029 (USD MILLION)
             10.3.5 ITALY
                        10.3.5.1 High R&D spending to support market growth
                                      TABLE 194 ITALY: EMPTY CAPSULES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 195 ITALY: GELATIN CAPSULES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 196 ITALY: NON-GELATIN CAPSULES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 197 ITALY: MARKET, BY FUNCTIONALITY, 2022–2029 (USD MILLION)
                                      TABLE 198 ITALY: MARKET, BY THERAPEUTIC APPLICATION, 2022–2029 (USD MILLION)
                                      TABLE 199 ITALY: EMPTY CAPSULES MARKET, BY END USER, 2022–2029 (USD MILLION)
             10.3.6 SPAIN
                        10.3.6.1 Low production costs to drive market
                                      TABLE 200 SPAIN: EMPTY CAPSULES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 201 SPAIN: GELATIN CAPSULES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 202 SPAIN: NON-GELATIN CAPSULES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 203 SPAIN: MARKET, BY FUNCTIONALITY, 2022–2029 (USD MILLION)
                                      TABLE 204 SPAIN: MARKET, BY THERAPEUTIC APPLICATION, 2022–2029 (USD MILLION)
                                      TABLE 205 SPAIN: MARKET, BY END USER, 2022–2029 (USD MILLION)
             10.3.7 REST OF EUROPE
                        TABLE 206 REST OF EUROPE: EMPTY CAPSULES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 207 REST OF EUROPE: GELATIN CAPSULES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 208 REST OF EUROPE: NON-GELATIN CAPSULES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 209 REST OF EUROPE: MARKET, BY FUNCTIONALITY, 2022–2029 (USD MILLION)
                        TABLE 210 REST OF EUROPE: MARKET, BY THERAPEUTIC APPLICATION, 2022–2029 (USD MILLION)
                        TABLE 211 REST OF EUROPE: MARKET, BY END USER, 2022–2029 (USD MILLION)
     10.4 ASIA PACIFIC 
             10.4.1 ASIA PACIFIC: RECESSION IMPACT
                        FIGURE 32 ASIA PACIFIC: EMPTY CAPSULES MARKET SNAPSHOT
                        TABLE 212 ASIA PACIFIC: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                        TABLE 213 ASIA PACIFIC: MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 214 ASIA PACIFIC: GELATIN CAPSULES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 215 ASIA PACIFIC: NON-GELATIN CAPSULES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 216 ASIA PACIFIC: MARKET, BY FUNCTIONALITY, 2022–2029 (USD MILLION)
                        TABLE 217 ASIA PACIFIC: MARKET, BY THERAPEUTIC APPLICATION, 2022–2029 (USD MILLION)
                        TABLE 218 ASIA PACIFIC: EMPTY CAPSULES MARKET, BY END USER, 2022–2029 (USD MILLION)
             10.4.2 CHINA
                        10.4.2.1 Rising incidence of infectious diseases and increasing market
                                      TABLE 219 CHINA: EMPTY CAPSULES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 220 CHINA: GELATIN CAPSULES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 221 CHINA: NON-GELATIN CAPSULES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 222 CHINA: MARKET, BY FUNCTIONALITY, 2022–2029 (USD MILLION)
                                      TABLE 223 CHINA: MARKET, BY THERAPEUTIC APPLICATION, 2022–2029 (USD MILLION)
                                      TABLE 224 CHINA: EMPTY CAPSULES MARKET, BY END USER, 2022–2029 (USD MILLION)
             10.4.3 INDIA
                        10.4.3.1 Growth in pharmaceutical industry to boost demand
                                      TABLE 225 INDIA: EMPTY CAPSULES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 226 INDIA: GELATIN CAPSULES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 227 INDIA: NON-GELATIN CAPSULES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 228 INDIA: MARKET, BY FUNCTIONALITY, 2022–2029 (USD MILLION)
                                      TABLE 229 INDIA: MARKET, BY THERAPEUTIC APPLICATION, 2022–2029 (USD MILLION)
                                      TABLE 230 INDIA: MARKET, BY END USER, 2022–2029 (USD MILLION)
             10.4.4 JAPAN
                        10.4.4.1 Rising advancements in drug delivery technologies to boost demand
                                      TABLE 231 JAPAN: EMPTY CAPSULES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 232 JAPAN: GELATIN CAPSULES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 233 JAPAN: NON-GELATIN CAPSULES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 234 JAPAN: MARKET, BY FUNCTIONALITY, 2022–2029 (USD MILLION)
                                      TABLE 235 JAPAN: MARKET, BY THERAPEUTIC APPLICATION, 2022–2029 (USD MILLION)
                                      TABLE 236 JAPAN: MARKET, BY END USER, 2022–2029 (USD MILLION)
             10.4.5 SOUTH KOREA
                        10.4.5.1 Presence of several pharmaceutical manufacturers to fuel market
                                      TABLE 237 SOUTH KOREA: EMPTY CAPSULES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 238 SOUTH KOREA: GELATIN CAPSULES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 239 SOUTH KOREA: NON-GELATIN CAPSULES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 240 SOUTH KOREA: MARKET, BY FUNCTIONALITY, 2022–2029 (USD MILLION)
                                      TABLE 241 SOUTH KOREA: MARKET, BY THERAPEUTIC APPLICATION, 2022–2029 (USD MILLION)
                                      TABLE 242 SOUTH KOREA: EMPTY CAPSULES MARKET, BY END USER, 2022–2029 (USD MILLION)
             10.4.6 REST OF ASIA PACIFIC
                        TABLE 243 REST OF ASIA PACIFIC: EMPTY CAPSULES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 244 REST OF ASIA PACIFIC: GELATIN CAPSULES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 245 REST OF ASIA PACIFIC: NON-GELATIN CAPSULES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 246 REST OF ASIA PACIFIC: MARKET, BY FUNCTIONALITY, 2022–2029 (USD MILLION)
                        TABLE 247 REST OF ASIA PACIFIC: MARKET, BY THERAPEUTIC APPLICATION, 2022–2029 (USD MILLION)
                        TABLE 248 REST OF ASIA PACIFIC: EMPTY CAPSULES MARKET, BY END USER, 2022–2029 (USD MILLION)
     10.5 LATIN AMERICA 
             10.5.1 LATIN AMERICA: RECESSION IMPACT
                        TABLE 249 LATIN AMERICA: EMPTY CAPSULES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                        TABLE 250 LATIN AMERICA: MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 251 LATIN AMERICA: GELATIN CAPSULES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 252 LATIN AMERICA: NON-GELATIN CAPSULES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 253 LATIN AMERICA: MARKET, BY FUNCTIONALITY, 2022–2029 (USD MILLION)
                        TABLE 254 LATIN AMERICA: MARKET, BY THERAPEUTIC APPLICATION, 2022–2029 (USD MILLION)
                        TABLE 255 LATIN AMERICA: MARKET, BY END USER, 2022–2029 (USD MILLION)
             10.5.2 BRAZIL
                        10.5.2.1 High export of generics to support market growth
                                      TABLE 256 BRAZIL: EMPTY CAPSULES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 257 BRAZIL: GELATIN CAPSULES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 258 BRAZIL: NON-GELATIN CAPSULES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 259 BRAZIL: MARKET, BY FUNCTIONALITY, 2022–2029 (USD MILLION)
                                      TABLE 260 BRAZIL: MARKET, BY THERAPEUTIC APPLICATION, 2022–2029 (USD MILLION)
                                      TABLE 261 BRAZIL: MARKET, BY END USER, 2022–2029 (USD MILLION)
             10.5.3 MEXICO
                        10.5.3.1 Favorable healthcare regulations to fuel market
                                      TABLE 262 MEXICO: EMPTY CAPSULES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 263 MEXICO: GELATIN CAPSULES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 264 MEXICO: NON-GELATIN CAPSULES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 265 MEXICO: MARKET, BY FUNCTIONALITY, 2022–2029 (USD MILLION)
                                      TABLE 266 MEXICO: MARKET, BY THERAPEUTIC APPLICATION, 2022–2029 (USD MILLION)
                                      TABLE 267 MEXICO: EMPTY CAPSULES MARKET, BY END USER, 2022–2029 (USD MILLION)
             10.5.4 REST OF LATIN AMERICA
                        TABLE 268 REST OF LATIN AMERICA: EMPTY CAPSULES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 269 REST OF LATIN AMERICA: GELATIN CAPSULES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 270 REST OF LATIN AMERICA: NON-GELATIN CAPSULES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 271 REST OF LATIN AMERICA: MARKET, BY FUNCTIONALITY, 2022–2029 (USD MILLION)
                        TABLE 272 REST OF LATIN AMERICA: MARKET, BY THERAPEUTIC APPLICATION, 2022–2029 (USD MILLION)
                        TABLE 273 REST OF LATIN AMERICA: EMPTY CAPSULES MARKET, BY END USER, 2022–2029 (USD MILLION)
     10.6 MIDDLE EAST 
             10.6.1 RISING DEMAND FOR HALAL-CERTIFIED PRODUCTS TO DRIVE MARKET
             10.6.2 MIDDLE EAST: RECESSION IMPACT
                        TABLE 274 MIDDLE EAST: EMPTY CAPSULES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 275 MIDDLE EAST: GELATIN CAPSULES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 276 MIDDLE EAST: NON-GELATIN CAPSULES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 277 MIDDLE EAST: MARKET, BY FUNCTIONALITY, 2022–2029 (USD MILLION)
                        TABLE 278 MIDDLE EAST: MARKET, BY THERAPEUTIC APPLICATION, 2022–2029 (USD MILLION)
                        TABLE 279 MIDDLE EAST: MARKET, BY END USER, 2022–2029 (USD MILLION)
     10.7 AFRICA 
             10.7.1 RISING FOCUS ON API DEVELOPMENT TO SUPPORT MARKET GROWTH
             10.7.2 AFRICA: RECESSION IMPACT
                        TABLE 280 AFRICA: EMPTY CAPSULES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 281 AFRICA: GELATIN CAPSULES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 282 AFRICA: NON-GELATIN CAPSULES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 283 AFRICA: MARKET, BY FUNCTIONALITY, 2022–2029 (USD MILLION)
                        TABLE 284 AFRICA: MARKET, BY THERAPEUTIC APPLICATION, 2022–2029 (USD MILLION)
                        TABLE 285 AFRICA: MARKET, BY END USER, 2022–2029 (USD MILLION)
 
11 COMPETITIVE LANDSCAPE (Page No. - 248)
     11.1 OVERVIEW 
     11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 
             11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN EMPTY CAPSULES MARKET
                       TABLE 286 OVERVIEW OF STRATEGIES DEPLOYED BY KEY MANUFACTURING COMPANIES
     11.3 REVENUE ANALYSIS 
             FIGURE 33 REVENUE ANALYSIS OF KEY PLAYERS IN EMPTY CAPSULES INDUSTRY, 2021–2023 (USD MILLION)
     11.4 MARKET SHARE ANALYSIS 
             FIGURE 34 EMPTY CAPSULES INDUSTRY SHARE ANALYSIS, BY KEY PLAYER (2023)
             TABLE 287 EMPTY CAPSULES INDUSTRY: DEGREE OF COMPETITION
     11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 
             11.5.1 STARS
             11.5.2 EMERGING LEADERS
             11.5.3 PERVASIVE PLAYERS
             11.5.4 PARTICIPANTS
                        FIGURE 35 EMPTY CAPSULES INDUSTRY: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
             11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
                        11.5.5.1 Company footprint
                                      FIGURE 36 EMPTY CAPSULES INDUSTRY: COMPANY FOOTPRINT
                        11.5.5.2 Region footprint
                                      TABLE 288 EMPTY CAPSULES INDUSTRY: REGION FOOTPRINT
                        11.5.5.3 Type footprint
                                      TABLE 289 EMPTY CAPSULES INDUSTRY: TYPE FOOTPRINT
                        11.5.5.4 Functionality footprint
                                      TABLE 290 EMPTY CAPSULES INDUSTRY: FUNCTIONALITY FOOTPRINT
                        11.5.5.5 End-user footprint
                                      TABLE 291 EMPTY CAPSULES INDUSTRY: END-USER FOOTPRINT
     11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 
             11.6.1 PROGRESSIVE COMPANIES
             11.6.2 RESPONSIVE COMPANIES
             11.6.3 DYNAMIC COMPANIES
             11.6.4 STARTING BLOCKS
                        FIGURE 37 EMPTY CAPSULES INDUSTRY: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
             11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
                       TABLE 292 EMPTY CAPSULES INDUSTRY: DETAILED LIST OF KEY STARTUPS/SMES
                       TABLE 293 EMPTY CAPSULES INDUSTRY: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
     11.7 COMPANY VALUATION & FINANCIAL METRICS 
             FIGURE 38 EV/EBITDA OF KEY VENDORS
             FIGURE 39 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
     11.8 BRAND/PRODUCT COMPARISON 
             FIGURE 40 EMPTY CAPSULES INDUSTRY: BRAND/PRODUCT COMPARATIVE ANALYSIS
     11.9 COMPETITIVE SCENARIO 
             11.9.1 PRODUCT LAUNCHES & APPROVALS
                       TABLE 294 EMPTY CAPSULES INDUSTRY: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021– MAY 2024
             11.9.2 DEALS
                       TABLE 295 EMPTY CAPSULES INDUSTRY: DEALS, JANUARY 2021–MAY 2024
             11.9.3 EXPANSIONS
                       TABLE 296 EMPTY CAPSULES INDUSTRY: EXPANSIONS, JANUARY 2021–MAY 2024
             11.9.4 OTHER DEVELOPMENTS
                       TABLE 297 EMPTY CAPSULES INDUSTRY: OTHER DEVELOPMENTS, JANUARY 2021–MAY 2024
 
12 COMPANY PROFILES (Page No. - 270)
(Business Overview, Products Offered, Recent Developments, MnM View Right to win, Strategic choices made, Weaknesses and competitive threats) *
     12.1 KEY PLAYERS 
             12.1.1 CAPSUGEL (LONZA)
                       TABLE 298 LONZA: COMPANY OVERVIEW
                        FIGURE 41 LONZA: COMPANY SNAPSHOT (2023)
                       TABLE 299 CAPSUGEL (LONZA): PRODUCTS OFFERED
                       TABLE 300 CAPSUGEL (LONZA): PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–MAY 2024
                       TABLE 301 CAPSUGEL (LONZA): OTHER DEVELOPMENTS, JANUARY 2021–MAY 2024
             12.1.2 ACG
                       TABLE 302 ACG: COMPANY OVERVIEW
                       TABLE 303 ACG: PRODUCTS OFFERED
                       TABLE 304 ACG: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–MAY 2024
                       TABLE 305 ACG: DEALS, JANUARY 2021–MAY 2024
                       TABLE 306 ACG: OTHER DEVELOPMENTS, JANUARY 2021–MAY 2024
             12.1.3 QUALICAPS (ROQUETTE FRÈRES)
                       TABLE 307 QUALICAPS (ROQUETTE FRÈRES): COMPANY OVERVIEW
                       TABLE 308 QUALICAPS (ROQUETTE FRÈRES): PRODUCTS OFFERED
                       TABLE 309 QUALICAPS (ROQUETTE FRÈRES): PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–MAY 2024
                       TABLE 310 QUALICAPS (ROQUETTE FRÈRES): DEALS, JANUARY 2021–MAY 2024
                       TABLE 311 QUALICAPS (ROQUETTE FRÈRES): OTHER DEVELOPMENTS, JANUARY 2021–MAY 2024
             12.1.4 SUHEUNG
                       TABLE 312 SUHEUNG: COMPANY OVERVIEW
                        FIGURE 42 SUHEUNG: COMPANY SNAPSHOT (2023)
                       TABLE 313 SUHEUNG: PRODUCTS OFFERED
                       TABLE 314 SUHEUNG: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–MAY 2024
             12.1.5 SHANXI GUANGSHENG CAPSULE LIMITED
                       TABLE 315 SHANXI GUANGSHENG CAPSULE LIMITED: COMPANY OVERVIEW
                       TABLE 316 SHANXI GUANGSHENG CAPSULE LIMITED: PRODUCTS OFFERED
                       TABLE 317 SHANXI GUANGSHENG CAPSULE LIMITED: OTHER DEVELOPMENTS, JANUARY 2021– MAY 2024
             12.1.6 CAPSCANADA (LYFE GROUP)
                       TABLE 318 CAPSCANADA (LYFE GROUP): COMPANY OVERVIEW
                       TABLE 319 CAPSCANADA (LYFE GROUP): PRODUCTS OFFERED
             12.1.7 HEALTHCAPS INDIA
                       TABLE 320 HEALTHCAPS INDIA: COMPANY OVERVIEW
                        FIGURE 43 HEALTHCAPS INDIA: COMPANY SNAPSHOT (2022)
                       TABLE 321 HEALTHCAPS INDIA: PRODUCTS OFFERED
             12.1.8 NECTAR LIFESCIENCES LTD.
                       TABLE 322 NECTAR LIFESCIENCES LTD.: COMPANY OVERVIEW
                        FIGURE 44 NECTAR LIFESCIENCES LTD.: COMPANY SNAPSHOT (2022)
                       TABLE 323 NECTAR LIFESCIENCES LTD.: PRODUCTS OFFERED
             12.1.9 SUNIL HEALTHCARE LIMITED
                       TABLE 324 SUNIL HEALTHCARE LIMITED: COMPANY OVERVIEW
                        FIGURE 45 SUNIL HEALTHCARE LIMITED COMPANY SNAPSHOT (2022)
                       TABLE 325 SUNIL HEALTHCARE LIMITED: PRODUCTS OFFERED
             12.1.10 FARMACAPSULAS
                       TABLE 326 FARMACAPSULAS: COMPANY OVERVIEW
                       TABLE 327 FARMACAPSULAS: PRODUCTS OFFERED
             12.1.11 NATURAL CAPSULES LIMITED
                       TABLE 328 NATURAL CAPSULES LIMITED: COMPANY OVERVIEW
                        FIGURE 46 NATURAL CAPSULES LIMITED: COMPANY SNAPSHOT (2023)
                       TABLE 329 NATURAL CAPSULES LIMITED: PRODUCTS OFFERED
                       TABLE 330 NATURAL CAPSULES LIMITED: OTHER DEVELOPMENTS, JANUARY 2021–MAY 2024
             12.1.12 ERAWAT PHARMA LIMITED
                       TABLE 331 ERAWAT PHARMA LIMITED: COMPANY OVERVIEW
                       TABLE 332 ERAWAT PHARMA LIMITED: PRODUCTS OFFERED
             12.1.13 QINGDAO YIQING BIOTECHNOLOGY CO., LTD. (BAOTOU DONGBAO BIO-TECH CO., LTD.)
                       TABLE 333 QINGDAO YIQING BIOTECHNOLOGY CO., LTD. (BAOTOU DONGBAO BIO-TECH CO., LTD.): COMPANY OVERVIEW
                        FIGURE 47 BAOTOU DONGBAO BIO-TECH CO., LTD.: COMPANY SNAPSHOT (2022)
                       TABLE 334 QINGDAO YIQING BIOTECHNOLOGY CO., LTD. (BAOTOU DONGBAO BIO-TECH CO., LTD.): PRODUCTS OFFERED
                       TABLE 335 QINGDAO YIQING BIOTECHNOLOGY CO., LTD. (BAOTOU DONGBAO BIO-TECH CO., LTD.): PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–MAY 2024
             12.1.14 FORTCAPS (KUMAR ORGANIC PRODUCTS LIMITED)
                       TABLE 336 FORTCAPS (KUMAR ORGANIC PRODUCTS LIMITED): COMPANY OVERVIEW
                       TABLE 337 FORTCAPS (KUMAR ORGANIC PRODUCTS LIMITED): PRODUCTS OFFERED
                       TABLE 338 FORTCAPS (KUMAR ORGANIC PRODUCTS LIMITED): DEALS, JANUARY 2021–MAY 2024
             12.1.15 COMED CHEMICALS LIMITED
                       TABLE 339 COMED CHEMICALS LIMITED: COMPANY OVERVIEW
                        FIGURE 48 COMED CHEMICALS LIMITED: COMPANY SNAPSHOT (2022)
                       TABLE 340 COMED CHEMICALS LIMITED: PRODUCTS OFFERED
     12.2 OTHER PLAYERS 
             12.2.1 SAVIOURCAPS
                       TABLE 341 SAVIOURCAPS: COMPANY OVERVIEW
             12.2.2 SHANXI JC BIOLOGICAL TECHNOLOGY CO.
                       TABLE 342 SHANXI JC BIOLOGICAL TECHNOLOGY CO.: COMPANY OVERVIEW
             12.2.3 ROXLOR
                       TABLE 343 ROXLOR: COMPANY OVERVIEW
             12.2.4 MEDISCA INC.
                       TABLE 344 MEDISCA INC.: COMPANY OVERVIEW
             12.2.5 ZHEJIANG YUEXI CAPSULE CO., LTD.
                       TABLE 345 ZHEJIANG YUEXI CAPSULE CO., LTD.: COMPANY OVERVIEW
             12.2.6 SHAOXING KANGKE CAPSULE CO., LTD.
                       TABLE 346 SHAOXING KANGKE CAPSULE CO., LTD.: BUSINESS OVERVIEW
             12.2.7 ZHEJIANG HUILI CAPSULES CO., LTD.
                       TABLE 347 ZHEJIANG HUILI CAPSULES CO., LTD.: COMPANY OVERVIEW
             12.2.8 SHAOXING ZHONGYA CAPSULE CO., LTD.
                       TABLE 348 SHAOXING ZHONGYA CAPSULE CO., LTD.: COMPANY OVERVIEW
             12.2.9 SHING LIH FANG ENTERPRISE CO., LTD.
                       TABLE 349 SHING LIH FANG ENTERPRISE CO., LTD.: COMPANY OVERVIEW
             12.2.10 LEFANCAPS
                       TABLE 350 LEFANCAPS: COMPANY OVERVIEW
             12.2.11 CHEMCAPS LIMITED
                       TABLE 351 CHEMCAPS LIMITED: COMPANY OVERVIEW
             12.2.12 BIO-CAPS INDIA LTD.
                       TABLE 352 BIO-CAPS INDIA LTD.: COMPANY OVERVIEW
             12.2.13 BIOCAPS ENTERPRISE
                       TABLE 353 BIOCAPS ENTERPRISE: COMPANY OVERVIEW
             12.2.14 SNAIL PHARMA INDUSTRY
                       TABLE 354 SNAIL PHARMA INDUSTRY: COMPANY OVERVIEW
             12.2.15 BRIGHT PHARMA CAPS
                       TABLE 355 BRIGHT PHARMA CAPS: COMPANY OVERVIEW
             12.2.16 SHREE PHARMA CAPS
                       TABLE 356 SHREE PHARMA CAPS: COMPANY OVERVIEW
 
*Details on Business Overview, Products Offered, Recent Developments, MnM View, Right to win, Strategic choices made, Weaknesses and competitive threats might not be captured in case of unlisted companies.
 
13 APPENDIX (Page No. - 324)
     13.1 DISCUSSION GUIDE 
     13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 
     13.3 CUSTOMIZATION OPTIONS 
     13.4 RELATED REPORTS 
     13.5 AUTHOR DETAILS 

This research study involved the extensive use of secondary sources, directories, and databases to identify and collect valuable information for the analysis of the global empty capsules market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess the growth prospects of the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.

Secondary Research

Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the empty capsules market. The secondary sources used for this study include European Federation of Pharmaceutical Industries and Associations (EFPIA), United States Food and Drug Administration (US FDA), Central Drugs Standard Control Organisation (CDSCO), Drugs Technical Advisory Board (DTAB), Pharmaceutical Research and Manufacturers of America (PhRMA), Indian Pharmaceutical Association (IPA), National Institutes of Health (NIH), Molecular Diversity Preservation International (MDPI), World Health Organization (WHO). Secondary sources also include corporate and regulatory filings (such as annual reports, SEC filings, investor presentations, and financial statements), business magazines and research journals, press releases, and trade, business, and professional associations. These sources were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.

Primary Research

Extensive primary research was conducted after acquiring basic knowledge about the global empty capsules market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (personnel from pharmaceutical companies, nutraceutical companies and reference laboratories) and supply side (C-level and D-level executives, product managers, and marketing and sales managers of key manufacturers, distributors, and channel partners, among others, from Tier 1 and Tier 2 companies engaged in offering products) across five major regions—North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. Approximately 80% of primary interviews were conducted with supply-side representatives, while demand-side participants accounted for the remaining share. This preliminary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

Empty Capsules Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the empty capsules market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

Bottom-up Approach

  • The key players in the industry and market have been identified through extensive secondary research.
  • The revenues generated from the empty capsules business of leading players have been determined through primary and secondary research.
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

Top-down Approach

After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments.

Empty Capsules Market Size, and Share

Data Triangulation

To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Market Definition

A capsule is a form of solid oral dosage, which consists of a container, usually made of gelatin or HPMC material and filled with a medicinal substance. Empty capsules are hard shells of various shapes and have a capacity of usually a single dose of the active ingredient. Empty capsules contain dry, powdered ingredients or miniature pellets. These are made in two halves—a smaller-diameter “body” that is filled and then sealed using a larger-diameter “cap.”.

The scope of this report includes products gelatin and non-gelatin empty capsules which are utilized by various industries such as pharmaceutical, nutraceutical, and cosmetic for various type of applications including medicine, dietary supplements and cosmetics.

Stakeholders

  • Empty capsules manufacturers, vendors, and distributors
  • Pharmaceutical companies
  • Nutraceutical companies
  • Cosmeceutical companies
  • Research laboratories
  • Life Science Companies
  • Venture Capitalists and Investors
  • Government Organizations
  • Private Research Firms

Report Objectives

  • To define, describe, and forecast the empty capsules market based on type, functionality, therapeutic application, end user, and region.
  • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges).
  • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall empty capsules market.
  • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders.
  • To forecast the size of the market segments with respect to six main regions, namely, North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa.
  • To profile the key players in the empty capsules market and comprehensively analyze their product portfolios, market positions, and core competencies.
  • To track and analyze competitive developments such as acquisitions, product launches, expansions, agreements, partnerships, and collaborations in the empty capsules market.
  • To benchmark players within the empty capsules market using the ‘Company Evaluation Matrix' framework, which analyzes market players based on various parameters within the broad categories of business and product strategy.

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Geographic Analysis

  • Further breakdown of the Rest of Europe empty capsules market, by country
  • Further breakdown of the Rest of Asia Pacific empty capsules market, by country
  • Further breakdown of the Rest of Latin America empty capsules market, by country

Company Information

  • Detailed analysis and profiling of additional market players (up to five)
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Request Customization

Instant Answers with GPT - Ask Now!

Ask real questions. Get complete answers !
Report Code
PH 2935
Published ON
Jun, 2024
REQUEST FREE SAMPLE REPORT
Choose License Type
BUY NOW
Inquire Before Buying
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Empty Capsules Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2024 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status Website Feedback